Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia.
D002066:Busulfan / Q000627:therapeutic use*; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid / Q000628:therapy*; D014265:Triethylenemelamine / Q000627:therapeutic use*
D014265:Triethylenemelamine; D002066:Busulfan
BUSULFAN/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy; TRIETHYLENE MELAMINE/therapeutic use